Tim Watts, CFO at Shield Therapeutics #STX presenting at our Life Sciences Investor Briefing Watch Now

Shant

Shant

Shant primarily covers the G10 FX majors and analysis on the rates and currency markets, based on 20 years of experience, primarily in spot FX and options, including as an inter-bank trader at a leading Scandinavian retail name.

Giving a broad and balanced view on determining underlying sentiment, adaptability is key in the current climate which is ever more dynamic. Emerging market currencies are also coming to the fore and are having a greater influence on the leading currencies, which is within Shant's analytical remit.

He focuses on the fundamental factors influencing trade, but incorporates technical and historical factors in forecasting directional views.

Most Recent Blog Posts

Shant

UK retailers hold key talks with the government today over no-deal supply issues

20th September 2019 By: Shant

On Thursday, top retailers in the UK met with government officials in what is being described as 'clear the air' talks oversupply issues should the UK indeed crash out of the EU without a deal next mo...

Read More
Shant

A sign of the valuation 'adjustments' to come?

17th September 2019 By: Shant

We hear that the keenly anticipated IPO of WeCompany - the parent of WeWork - is to be delayed until later this year.   Initial expectations were that the stock market listing was to be conducted...

Read More
Shant

US consumer discretionary riding (the) high(s)

13th September 2019 By: Shant

Going into Friday's session, US consumer discretionary stocks are riding the crest of another wave higher, fuelled by a mix of fresh optimism of a trade deal between the US and China, as well as the p...

Read More
Shant

London Stock Exchange receives a £32bln bid from Hong Kong

11th September 2019 By: Shant

Shares in the London Stock Exchange ramped up earlier today on news that the owner of Hong Kong's major share market, HKEX had made a surprise bid of £32bln for the UK's primary stock exchange.&...

Read More
Shant

More Brexit delays ahead

6th September 2019 By: Shant

Well, it seems another Brexit deadline is set to pass uneventfully, with the last month or so seeing heightened panic as the government of the day impressed their intentions to push the UK to the brin...

Read More
Shant

Negative rates don't suit everybody

6th September 2019 By: Shant

These are tough times to look ahead for any fund manager, and no more so than for those mandated to pension funds who are dictated by liability-driven investments.  In the current economic climat...

Read More
Shant

Pharmaceuticals see their 'defensive' credentials tested again.

29th August 2019 By: Shant

It is well established that pharmaceutical stocks are the go-to sector when investors are looking to reduce their exposure to riskier assets.  Staples offering more moderate returns suddenly look...

Read More
Shant

Fed policy under the spotlight again as Fed chair Powell addresses Jackson Hole.

23rd August 2019 By: Shant

One gets the sense that the financial markets are still banking on the 'Fed put' in current times - the notion that the central bank will come in to support any weakness through policy - with the Whit...

Read More
Shant

Greene King shares ramped up after Hong Kong's CKA agrees on purchase

22nd August 2019 By: Shant

Share in Greene King spiked 50% at the start of the week on news that the Hong Kong firm CKA, founded by Li Ka-Shing, has agreed to buy the Suffolk based brewery.  This follows a developing trend...

Read More
Shant

GE shares take another tumble as fall from grace continues

16th August 2019 By: Shant

Shares in GE took another tumble yesterday after an investigator who unraveled the Ponzi scheme initiated by Bernie Madoff warned of 'hidden' liabilities within the company's accounts related to its i...

Read More

Login to your account

Don't have an account? Click here to register.